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Essentra Scientific Services, Shaftesbury Avenue, Jarrow, Tyne and Wear NE32 3UP, UK SUMMARY Electronic cigarettes (e-cigs) provide a smoke-free alternative for inhalation of nicotine without the vast array of toxic and carcinogenic combustion products produced by tobacco smoke. Elevated levels of toxic carbonyls may be generated during vaporisation; however, it is unclear whether that is indicative of a fault with the device or is due to the applied conditions of the test. A device, designed and built at this facility, was tested to determine the levels of selected toxic carbonyls. The reservoir was filled with approximately 960 mg of an e-liquid formulation containing 1.8% (w/v) nicotine. Devices were puffed 200 times in blocks of 40 using a standardised regime consisting of a 55 mL puff volume; 3 s puff duration; 30 s puff interval; square wave puff profile. Confirmatory testing for nicotine and total aerosol delivery resulted in mean (n = 8) values of 10 mg (RSD 12.3%) and 716 mg (RSD 11.2%), respectively. Emissions of toxic carbonyls were highly variable yet were between < 0.1% and 22.9% of expected levels from a Kentucky Reference Cigarette (K3R4F) puffed 200 times under Health Canada Intense smoking conditions. It has been shown that a device built to a high specification with relatively consistent nicotine and aerosol delivery emits inconsistent levels of carbonyls. The exposure is greatly reduced when compared with lit tobacco products. However, it was observed that as the reservoirs neared depletion then emission levels were significantly higher. [Beitr. Tabakforsch. Int. 27 (2016) (3) . It has been proposed that e-cigs which are not marketed for 'therapeutic purposes' are to be classified as tobacco products. Therefore, a clear distinction has emerged between consumer tobacco products and therapeutic devices which would require a pharmaceutical licence. The rise in popularity of e-cigs has made them an important part of the strategy towards tobacco harm reduction (4). The revised European Union (EU) Tobacco Products Directive (TPD2) is due to be implemented in May 2016 (5) . Member states are required to enact legislation to ensure compliance with the directive. Article 20 of the directive relates specifically to e-cigs. Manufacturers and importers of e-cig devices and refill containers will be subject to reporting obligations, restrictions on unit volumes, and nicotine concentrations with a maximum permissible limit in e-liquids of 20 mg/mL. Formulations with higher concentrations will be subject to Directive 2001/83/EC relating to medicinal products (6) . A proposed standard method is currently under development by the International Organization for Standardization (ISO) Technical Committee 126; responsible for tobacco and tobacco products (7) . Clearly e-cigs are not tobacco products in the conventional sense. Formulations may contain natural extracts of tobacco (NET) and, therefore, low levels of other tobacco-derived chemicals (8, 9) . However, distilled nicotine is also commonly used. The FDA has stated that insufficient data is currently available to determine what effects e-cigs have on the public health (3). Emissions vary considerably and a lack of uniformity in methods inhibits any useful comparison with lit tobacco products (10) . The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) has stated that whilst average levels of certain toxic and carcinogenic compounds were 1-2 orders of magnitude lower than tobacco smoke (11); levels of formaldehyde and acrolein, as high as those found in tobacco smoke, have been reported (12) . Proposed measures under TPD2 will require manufacturers to submit notifications including emission levels (5). However, the composition of the aerosol will depend on the ingredients used in the formulation and the thermal degradation products produced which will not be necessarily clear to either manufacturer or regulatory authority. Studies to date have tended to focus on known tobacco smoke constituents. The Health Canada list of 44 constituents (13) and the FDA list of 93 harmful and potentially harmful constituents (HPHC) in cigarette smoke and/or filler (14) , were formulated to determine exposure risk in lit products. These constituents are tobacco-derived or combustion/pyrolysis products of tobacco and it can be foreseen that e-cigs will not contain many of the chemicals listed. This paper focuses on toxic carbonyl content in the e-cig aerosol and whether elevated levels might be indicative of a fault with the device by making a comparison with the nicotine and aerosol delivery or if it is symptomatic of the applied test conditions.
HARMFUL CONSTITUENTS IN E-CIGS

E-liquids
The bulk of the liquid contained within an e-cig (e-liquid or e-juice) usually consists of propylene glycol (PG) and glycerol (VG) although ratios vary greatly. Nicotine may be added either by direct extraction from the tobacco leaf into the bulk constituents to give a NET or by addition of distilled nicotine which is usually plant-derived although it can be synthesised. The specification for EP/USP (European Pharmacopoeia/United States Pharmacopeia) pharma grade nicotine is > 99.0%. Formulations with 0% nicotine are also marketed. Water is usually also present. PG and VG are low toxicity compounds widely used in many products. Allergic reactions to PG have been documented in a minority of the population (15) . For this reason VG only formulations are readily available. Nicotine is a highly addictive substance and can be extremely toxic if ingested especially e-liquids containing high concentration formulations (16) .
Other chemicals may be added to facilitate the extraction process or to flavour or buffer the solution and are present at much lower concentrations. Certain chemicals have reportedly been used in formulations that are not toxic by ingestion but are respiratory toxins. Diacetyl and acetyl propionyl, used as flavours, have been detected in various formulations with many of them exposing users (or vapers) to higher than safe levels (17) . Certain impurities may also be present in the e-liquid. Nicotine that has been derived from the tobacco plant may contain carcinogenic tobacco-specific nitrosamines (TSNA) and phenols (9) . A study by ETTER et al. of 10 commercial refill e-liquids detected various minor tobacco alkaloids and nicotine degradation products (18) . The same study did not detect any ethylene glycol (EG) and diethylene glycol (DEG); however, an FDA commissioned study found trace levels of DEG in one commercial brand (19) . Toxic aldehydes, formaldehyde and acetaldehyde, have been detected in e-liquids (20) ; however, these chemicals are far more likely to be generated in the aerosol.
E-cig aerosol
It is likely that the e-liquid is contained within a reservoir often called the 'cartomiser' and is vaporised using a heater coil wrapped around a wicking material. E-cigs are battery powered which can be activated either by a flow sensor or manually. Unlike a conventional lit tobacco product there is no combustion and although some thermal decomposition may occur due to high temperature and contact with solid surfaces, the composition of the vapour remains essentially unchanged. Aerosolised PG and VG are relatively benign; however, inhalation of large volumes of PG has been shown to cause acute ocular and upper airway irritation (21) . Certain aldehyde compounds including formaldehyde, acetaldehyde, and acrolein have been found in e-cig aerosol (12) . They are thermal decomposition products of PG and VG. This has been demonstrated experimentally using pyrolysis analysis (22, 23) . Levels vary greatly from device to device and are affected by the amount of heat generated by the coil. Studies using 'tankstyle' devices with adjustable voltage output have demonstrated that emissions of formaldehyde and other toxic aldehydes may even exceed that of conventional cigarettes when operated at the higher voltage setting (24, 25) (26) . The elevated levels of aldehydes are caused by burning of the wicking material. The taste would be so unbearable that the vaper would cease puffing immediately. There is clearly a different set of criteria to what defines a cigarette performing normally to an e-cig. Particles from the various components contained within the device can be transferred to the aerosol. The heater coil is typically made from a nickel chromium alloy (nichrome) wrapped around the wicking material which is typically made from silica based fibreglass although other materials such as cotton may be used. The soldered joints and the plastic coatings are another possible source of emissions. Various metals including cadmium, chromium, lead and nickel have been detected in e-cig aerosol (12, 27, 28) . These metals are HPHCs cited by the FDA (14) . Silicate beads originating from the fibreglass wicks have also been detected in the aerosol (27) . Sources of other toxic emissions may be derived from impurities in the e-liquid. Known tobacco carcinogens such as TSNAs have been detected in the aerosol (12, 29) . These compounds may be present in NET formulations; however, endogenous production (30) , and formation during vaporisation may occur. Other tobacco-derived toxic chemicals such as phenols may be present. Typical temperatures produced by the e-cig heater coil (~ 200-250 °C under dry conditions) would not be expected to produce significant levels of pyrolysis products; however, studies do suggest that spikes in temperature due to drying of the wicking material produce elevated levels of toxic aldehydes (28) . Therefore, nicotine or additives could also decompose and produce toxic emissions.
METHODOLOGY
A standard method for determination of nicotine in eliquids is currently under development by the ISO (7). A standard set of machine conditions for sampling e-cig aerosol has been developed by the Cooperation Centre for Scientific Research Relevant to Tobacco (CORESTA). It proposes a standard puffing regime: 55 mL puff volume; 3 s puff duration; 30 s puff interval; square wave puff profile (31) . Standardised machine sampling of cigarettes is well established. The ISO 3308 standard method is used worldwide by the industry for the measurement of "tar", nicotine and carbon monoxide (32) . It provides a standard comparison across cigarette brands. It consists of a puffing regime of 35 mL puff volume; 2 s puff duration; 60 s puff interval; bell wave puff profile. The Health Canada Intense (HCI) smoking protocol consists of a puffing regime of 55 mL puff volume; 2 s puff duration; 30 s puff interval; bell wave puff profile with 100% ventilation blocking (33) . The CORESTA e-cig method (CRM 81) (31) is very similar to the HCI regime except that it incorporates a 3 s puff duration and also the bell wave puff profile was deemed unsuitable for ecigs because products activated by flow sensor must reach a certain pressure threshold and this can vary significantly from device to device. The square wave profile enables more reproducible puffs due to the rapid change in velocity at the commencement of the puff. It is reasonable to assume that other tobacco-specific methods will also be adapted for routine e-cig testing purposes. They include ISO 4387 (34) for determination of total particulate matter (TPM) and preparation for nicotine measurement, and CORESTA Recommended Method No. 74 (CRM 74) for determination of carbonyl compounds in cigarette mainstream smoke (MSS) (35) . Under TPD2 (5) manufacturers will be required to ensure nicotine delivery is consistent and toxic emissions are reported; however, without standardised methods it is difficult to have regulation in place.
IN-HOUSE TESTING
The e-cig device tested in this study was designed and built at this facility. The cartomiser (Figure 1 ) contained a midcoil atomiser consisting of a nichrome resistance wire wrapped around a fibreglass silica wick. The wick is in contact with a fibrous reservoir manufactured from polyester with a density of 0.13 g/cc. The heating coil operated at a resistance of 2.8 Ω. The applied voltage was a nominal output of 3.7 V which generated an output power of approximately 4.9 W. The type of battery was a rechargeable lithium ion. The cartomiser was filled with 0.8 mL e-liquid (approximately 960 mg) containing 18 mg/mL nicotine (Pharmacopoeia Europaea Grade) and the following other ingredients: propylene glycol, glycerol, vanilla extract, linalool, vanillin, menthol, malic acid, acetylpyrazine, ethyl acetate, ethyl maltol, trimethylpyrazine, tabanone, beta-damascenone, and water. Devices were puffed using a Cerulean SM450 20 Channel linear machine (Cerulean, Milton Keynes, U.K.) and operated in accordance with CRM 81 (31) . Devices were placed in holders containing labyrinth seals. Eight replicates of the device were tested for nicotine delivery and five replicates for carbonyl content. Each replicate was puffed 200 times and analysed in blocks of 40 puffs. The 200 puff cut-off ensured that none of the devices were empty by the end of the run. Nicotine delivery was determined based on ISO 4387 (34). The aerosol was trapped onto Cambridge filter (CF) glass fibre pads and extracted in 20 mL propan-2-ol containing decanol as an internal standard. Analysis was performed using gas chromatography with flame ionisation detection (GC-FID) ( Table 1) . The amount of aerosol trapped on the CF pads was determined gravimetrically. Carbonyl testing was based on CRM 74 (35) . The whole aerosol was scrubbed using 30 mL of acidified 2,4-dinitrophenylhydrazine (DNPH) solution. Analysis was performed using ultra-high performance liquid chromatography (UHPLC) with UV detection (Table 2 ).
RESULTS
The delivery of nicotine and aerosol in 8 replicates of the device remained relatively consistent over 5 × 40 puff blocks (Table 3) Table 4 . Five out of the eight carbonyls tested were found in the aerosol of this device at significant levels. Some methyl Various commercial e-cig brands have been tested by this laboratory and total carbonyls emissions found to range from < LOQ to > 1000 µg/puff block; however, the operating parameters between devices are so different that a reliable comparison was out of the scope of this study.
CONCLUSIONS
It has been shown that an e-cig device built to a high specification and which delivers relatively consistent quantities of nicotine and aerosol over 200 puffs emits inconsistent levels of carbonyls. The exposure is greatly reduced compared with lit tobacco products but levels of formaldehyde, acetaldehyde, and acrolein do exceed Workplace Exposure Limits defined by the UK Health and Safety Executive. It was observed that as the reservoirs neared depletion then emission levels were significantly higher. However, higher weight loss did not correlate with higher emissions. FARSALINOS et al. states that carbonyl emission levels are directly associated with 'dry-puff' conditions due to drying of the wicking material (26) . If this is the case then it is more symptomatic of the test conditions rather than the device. In this study weight losses were attained in blocks of 40 puffs; however, this does not mean that the vapour generated was evenly distributed. Advances in vaping machine technology may enable the aerosol density at every puff to be determined and allow the operator to identify if a dry-puff has occurred. Other factors causing elevated carbonyl levels should also be considered. It is expected that the heating element and wicking material will deteriorate with use and could subsequently lead to more thermal degradation. Charring of the wicking material was observed in the devices tested. Under normal operating conditions the carbonyl emissions were very low compared with lit cigarettes; however, elevated levels were observed in some of the later puff blocks which is most likely due to drying out of the wicking material. 
